Head and neck cancer Clinical Trials in Fullerton, CA
As of June 2026, 1 paid clinical trial is recruiting for Head and neck cancer in Fullerton, California. Recruiting Head and neck cancer studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Related specialties in Fullerton
Filter results
1 clinical trial for Head and neck cancer
·Clear filters·↓ Download CSVAbout research studies in Fullerton
Fullerton has approximately 100 recruiting research studies across a wide range of therapeutic areas. California hosts a dense network of world-class research institutions, including UC San Diego Health, Stanford Medicine, UCLA Health, UCSF, City of Hope, and Scripps Research. The state's thriving biotech corridor and diverse patient population make it a national hub for both early-phase and late-phase clinical research.
Top Research Study Locations in Fullerton
Researchers run research studies in Fullerton, CA at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Providence Medical Foundation | Advanced Solid Tumor, Esophageal Squamous Cell Carcinoma, Carcinoma, Non-Small Cell Lung | 27 |
| Providence St. Jude Medical Center | Non-Small Cell Lung Cancer, Advanced Breast Cancer, Advanced Ovarian Cancer | 7 |
| Retina Consultants of Orange County | Diabetic Macular Edema (DME), AMD, Age-related Macular Degeneration (AMD) | 7 |
| Neurology Center of North Orange County | AD, Agitation, Alzheimer Disease | 5 |
| Fullerton Neuro and Headache Ctr | Generalized Myasthenia Gravis, Secondary Progressive Multiple Sclerosis (SPMS) | 3 |
| Marshall B. Ketchum University | Amblyopia, Dry Eye Disease (DED), Myopia | 3 |
| Providence Saint Jude Medical Center | Metastatic Castration-resistant Prostate Cancer, Metastatic Colorectal Cancer, Prostate Cancer | 3 |
| Providence - St. Jude Medical Center | Hypothyroidism, Multiple Myeloma, Non Small Cell Lung Carcinoma | 3 |
| Fullerton Neurology and Headache Center | Alzheimer's Disease, Secondary Progressive Multiple Sclerosis | 2 |
| GSK Investigational Site | Chickenpox, Systemic Lupus Erythematosus | 2 |
| Saint Jude Medical Center | Malignant Neoplasm, Previously Treated Non-Small Cell Lung Cancer | 2 |
| Southern California College of Optometry at Marshall B. Ketchum University | Intermittent Exotropia, Myopia | 2 |
| St. Jude Medical Center | Atrial Fibrillation, Central Line Associated Blood Stream Infections (CLABSI), Intracerebral Hemorrhage | 2 |
| Providence Medical Foundation-Oncology | Breast Neoplasms, Diffuse Large B-Cell Lymphoma | 2 |
| Adverum Clinical | Neovascular Age-Related Macular Degeneration (nAMD), Wet AMD | 1 |
| Alliance Surgery Center, Inc | Lumbar Spinal Stenosis | 1 |
| Ascada Health PC dba Ascada Research | Coronavirus Disease (COVID-19) | 1 |
| Clinical Research Providence Medical Foundation | Small Cell Lung Cancer | 1 |
| Crosson Cancer Institute at Providence St. Jude Medical Center in Fullerton | Metastatic Pancreatic Adenocarcinoma, Metastatic Pancreatic Cancer, Pancreatic Cancer | 1 |
| Davita Fullerton Dialysis Center | Atherosclerotic Cardiovascular Disease in Patients With ESKD | 1 |
| Fullerton Neurological Center - Neurology | Chronic Migraine, Episodic Migraine | 1 |
| Laguna Surgery Center | Lumbar Spinal Stenosis | 1 |
| Local Institution - 0162 | Urothelial Cancer | 1 |
| Local Institution - 0581 | Carcinoma, Non-Small-Cell Lung | 1 |
| Marshall B. Ketchum University Southern California College of Optometry | Myopia | 1 |
Active & Upcoming Studies in Fullerton (2026)
Recruiting trials in Fullerton grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (48 active studies)
- IGNITE: Study of Tirabrutinib vs Rituximab/Temozolomide for Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL) · Phase 3 · Ono Pharmaceutical Co., Ltd.
- A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer · Phase 3 · Incyte Corporation
Eye & vision (9 active studies)
- Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Degeneration (AQUARIUS) · Phase 3 · Adverum Biotechnologies, Inc.
- The Effects of 3% Trehalose Ophthalmic Solution on Corneal Epithelial Barrier Function · Phase 4 · Southern California College of Optometry at Marshall B. Ketchum University
Neurology & pain (6 active studies)
- A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis · Phase 3 · Zenas BioPharma (USA), LLC
- A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis · Phase 3 · Novartis Pharmaceuticals
Vaccines (2 active studies)
- A Study to Evaluate the Safety and Efficacy of CD388 for Prevention of Influenza · Phase 3 · Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
- A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023) · Phase 3 · Merck Sharp & Dohme LLC
Diabetes & metabolic (2 active studies)
- A Research Study to See How a Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine, Both in Combination With Insulin Aspart, in Adults With Type 1 Diabetes · Phase 3 · Novo Nordisk A/S
- A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight and Chronic Low Back Pain · Phase 3 · Eli Lilly and Company
Cardiovascular (2 active studies)
- A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure · Phase 3 · AstraZeneca
- Anticoagulation in ICH Survivors for Stroke Prevention and Recovery · Phase 3 · Yale University
Common conditions studied in Fullerton
- Advanced Solid Tumor (4 active studies). Recruiting Advanced Solid Tumor studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Carcinoma, Non-Small-Cell Lung (4 active studies). Recruiting Carcinoma, Non-Small-Cell Lung studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Breast Neoplasms (3 active studies). Recruiting Breast Neoplasms studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Esophageal Squamous Cell Carcinoma (3 active studies). Recruiting Esophageal Squamous Cell Carcinoma studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Myopia (3 active studies). Recruiting Myopia studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- AMD (2 active studies). Recruiting AMD studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
Leading research sponsors in Fullerton
- Merck Sharp & Dohme LLC
- AbbVie
- Novartis Pharmaceuticals
- Amgen
- AstraZeneca
Local regulations and guidelines
Clinical trials in California are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. In addition, California-specific protections such as the California Consumer Privacy Act (CCPA) and the Confidentiality of Medical Information Act (CMIA) impose stringent data-privacy requirements on research involving California residents.
Compensation & what to expect
- How payment typically works
- Compensation is most often provided through reloadable electronic study cards or direct deposit, paid out per completed visit rather than as a lump sum. Amounts vary by the time required, the number of visits, and the study's complexity — overnight stays and inpatient pharmacology studies generally pay more than short outpatient surveys. The exact amount is disclosed in writing during informed consent before any visit.
- Healthy volunteers
- Healthy participants aged 18 and older can earn compensation by joining vaccine, pharmacology, and biomarker studies in Fullerton. These trials check how a new drug or vaccine behaves in healthy bodies before later-phase testing. Many sites maintain a healthy-volunteer registry so you hear about new opportunities first.
- What's included beyond payment
- Most trials cover study-related medical care at no cost — physical exams, lab work, imaging, the investigational treatment itself, and follow-up visits with the research team. Insurance is not required to participate. Free check-ups and access to specialists are common reasons participants return for additional studies.
- Travel and time
- Many sponsors reimburse travel, parking, mileage, and lost wages for visit days. Long-running studies and trials that require frequent visits often raise stipends accordingly. Ask the study coordinator for the visit schedule and reimbursement policy before you commit.
- Asking about compensation
- Compensation is set per protocol and per site, so figures are not published in trial registries. The fastest way to confirm payment for a specific study is to contact the recruiting site listed on the study record. Coordinators are accustomed to this question and will quote the per-visit and total amounts up front.
How to find a clinical trial in Fullerton
Hipa.ai aggregates every recruiting study in Fullerton from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
Frequently asked questions
How many paid clinical trials are currently recruiting in Fullerton?
There are approximately 100 recruiting clinical trials in Fullerton, California listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Fullerton pay participants?
Most recruiting trials in Fullerton compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Fullerton?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Fullerton?
The most common conditions under active study in Fullerton include Advanced Solid Tumor (4), Carcinoma, Non-Small-Cell Lung (4), Breast Neoplasms (3), Esophageal Squamous Cell Carcinoma (3), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Fullerton?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Fullerton on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Fullerton?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Fullerton?
Recruiting research sites in Fullerton include Providence Medical Foundation, Providence St. Jude Medical Center, Retina Consultants of Orange County, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Fullerton right now?
The largest active categories in Fullerton are Cancer & tumors (48), Eye & vision (9), Neurology & pain (6). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.